Norman David Eansor - 08 Jun 2021 Form 4 Insider Report for Marker Therapeutics, Inc. (MRKR)

Role
Director
Signature
/s/ Michael Loiacono, Attorney-in-Fact
Issuer symbol
MRKR
Transactions as of
08 Jun 2021
Net transactions value
$0
Form type
4
Filing time
10 Jun 2021, 18:54:11 UTC
Previous filing
08 Jun 2023
Next filing
10 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRKR Common Stock Award $0 +12,658 +52% $0.000000 36,940 08 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the portion of the annual board retainer for each non-employee director payable in immediately vested common stock under the Company's 2020 Equity Incentive Plan and based on the closing price of $3.16 per share, on the day immediately preceding the date of the Company's 2021 annual meeting.